Whipplewood Advisors LLC Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Whipplewood Advisors LLC bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 1,015 shares of the company’s stock, valued at approximately $79,000.

Several other institutional investors and hedge funds also recently made changes to their positions in GEHC. LGT Financial Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies during the third quarter valued at about $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter valued at about $26,000. Darwin Wealth Management LLC bought a new position in GE HealthCare Technologies during the third quarter valued at about $31,000. Finally, Continuum Advisory LLC grew its position in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Finally, Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Trading Down 2.3 %

Shares of GEHC opened at $87.35 on Friday. The firm’s 50 day simple moving average is $86.17 and its 200 day simple moving average is $86.10. The company has a market capitalization of $39.94 billion, a P/E ratio of 20.17, a P/E/G ratio of 3.19 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.